Market Trends ClearPoint Neuro gains FDA clearance for softwareBy admin8996erT0allJanuary 27, 2025 Monty Rakusen The U.S. FDA has granted 510(k) clearance to ClearPoint Neuro’s (NASDAQ:CLPT) ClearPoint Navigation Software Version 3.0. The system…
